Viewing Study NCT00684294


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2026-04-13 @ 11:49 AM
Study NCT ID: NCT00684294
Status: TERMINATED
Last Update Posted: 2020-03-02
First Post: 2008-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer
Sponsor: Mary Crowley Medical Research Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module